Jiangxi Fushine Pharmaceutical Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Jiangxi Fushine Pharmaceutical has a total shareholder equity of CN¥2.4B and total debt of CN¥1.6B, which brings its debt-to-equity ratio to 67.8%. Its total assets and total liabilities are CN¥4.6B and CN¥2.3B respectively.
Wichtige Informationen
67.8%
Verhältnis von Schulden zu Eigenkapital
CN¥1.62b
Verschuldung
| Zinsdeckungsgrad | n/a |
| Bargeld | CN¥676.89m |
| Eigenkapital | CN¥2.39b |
| Gesamtverbindlichkeiten | CN¥2.26b |
| Gesamtvermögen | CN¥4.65b |
Jüngste Berichte zur Finanzlage
Recent updates
There's Reason For Concern Over Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Massive 28% Price Jump
Oct 04
Is Jiangxi Fushine Pharmaceutical (SZSE:300497) A Risky Investment?
Jun 12What Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) 26% Share Price Gain Is Not Telling You
May 06Jiangxi Fushine Pharmaceutical Co., Ltd.'s (SZSE:300497) Business And Shares Still Trailing The Industry
Feb 27Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 300497's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.5B).
Langfristige Verbindlichkeiten: 300497's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥808.9M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 300497's net debt to equity ratio (39.4%) is considered satisfactory.
Schulden abbauen: 300497's debt to equity ratio has increased from 60.8% to 67.8% over the past 5 years.
Schuldendeckung: 300497's debt is not well covered by operating cash flow (6.3%).
Zinsdeckung: Insufficient data to determine if 300497's interest payments on its debt are well covered by EBIT.